Business Description
QuiaPEG Pharmaceuticals Holding AB
SIC : 111
ISIN : SE0020678159
Compare
Compare
Traded in other countries / regions
QUIA.Sweden99B0.Germany IPO Date
2005-06-21Description
QuiaPEG Pharmaceuticals Holding AB is a biotech company. It develops biopharmaceuticals based PEGylation technologies platform, which is applicable to proteins, peptides, and small molecules or oligonucleotides.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.35 | |||||
Debt-to-EBITDA | -4 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 90.5 | |||||
3-Year EPS without NRI Growth Rate | 90.2 | |||||
3-Year FCF Growth Rate | 87.6 | |||||
3-Year Book Growth Rate | 48.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.67 | |||||
9-Day RSI | 47.97 | |||||
14-Day RSI | 44.92 | |||||
6-1 Month Momentum % | -33.84 | |||||
12-1 Month Momentum % | -89.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.07 | |||||
Quick Ratio | 0.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -305.2 | |||||
Shareholder Yield % | 0.45 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -113.66 | |||||
ROA % | -33.32 | |||||
ROIC % | -19.29 | |||||
ROC (Joel Greenblatt) % | -1749.37 | |||||
ROCE % | -39.13 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.2 | |||||
EV-to-EBIT | -11.53 | |||||
EV-to-EBITDA | -15.54 | |||||
EV-to-FCF | -8.8 | |||||
Earnings Yield (Greenblatt) % | -8.67 | |||||
FCF Yield % | -15.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
QuiaPEG Pharmaceuticals Holding AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -1.989 | ||
Beta | 1.93 | ||
Volatility % | 149.12 | ||
14-Day RSI | 44.92 | ||
14-Day ATR (kr) | 0.005872 | ||
20-Day SMA (kr) | 0.040095 | ||
12-1 Month Momentum % | -89.82 | ||
52-Week Range (kr) | 0.0261 - 0.42 | ||
Shares Outstanding (Mil) | 1,489.98 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
QuiaPEG Pharmaceuticals Holding AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
QuiaPEG Pharmaceuticals Holding AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
QuiaPEG Pharmaceuticals Holding AB Frequently Asked Questions
What is QuiaPEG Pharmaceuticals Holding AB(OSTO:QUIA)'s stock price today?
The current price of OSTO:QUIA is kr0.04. The 52 week high of OSTO:QUIA is kr0.42 and 52 week low is kr0.03.
When is next earnings date of QuiaPEG Pharmaceuticals Holding AB(OSTO:QUIA)?
The next earnings date of QuiaPEG Pharmaceuticals Holding AB(OSTO:QUIA) is 2024-08-29.
Does QuiaPEG Pharmaceuticals Holding AB(OSTO:QUIA) pay dividends? If so, how much?
QuiaPEG Pharmaceuticals Holding AB(OSTO:QUIA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |